The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
Reasoning
The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
Cite this ruling
CBP Ruling N242521 (3004200060): The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300420
The tariff classification of Epirubicin (CAS-56420-45-2) Injection in dosage form, from Romania
The tariff classification of Cefadroxil (CAS-66592-87-8) imported in dosage/tablet form, from India
The tariff classification of Ceftibuten Dihydrate (CAS-97519-39-6) imported in dosage/tablet form, from India
The tariff classification of Cefpodoxime (CAS-82619-04-3) imported in dosage/tablet form, from India
The tariff classification of Cefixime (CAS-79350-37-1) imported in dosage/tablet form, from India